CD8A and neoplasm: Moreover, fully mature antigen-presenting cells (APCs) increase the cytotoxicity of CD8+ T cells and orchestrate Th1-dominant differentiation of CD4+ T cells, resulting in sustained and robust antitumor immunity, leading to long-term survival of tumor-bearing mice 9, 10.